S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:HZNP

Horizon Therapeutics Public Earnings Date, Estimates & History

$88.65
+2.46 (+2.85 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$81.44
Now: $88.65
$89.50
50-Day Range
$71.83
MA: $84.04
$95.48
52-Week Range
$23.81
Now: $88.65
$96.54
Volume1.87 million shs
Average Volume2.08 million shs
Market Capitalization$19.86 billion
P/E Ratio24.22
Dividend YieldN/A
Beta1.15

Earnings

Horizon Therapeutics Public (NASDAQ:HZNP) Earnings Information

Horizon Therapeutics Public last posted its earnings results on February 23rd, 2021. The biopharmaceutical company reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.22. Horizon Therapeutics Public has generated $1.94 earnings per share over the last year and currently has a price-to-earnings ratio of 24.2. Horizon Therapeutics Public has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 5th, 2021 based off prior year's report dates.

Horizon Therapeutics Public Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Horizon Therapeutics Public (NASDAQ:HZNP) Earnings Estimates

2021 EPS Consensus Estimate: $3.44
2022 EPS Consensus Estimate: $5.46
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20213$0.28$0.59$0.41
Q2 20213$0.68$0.95$0.78
Q3 20213$0.81$1.23$1.03
Q4 20212$1.08$1.35$1.22
Q1 20221$1.19$1.19$1.19
Q2 20221$1.30$1.30$1.30
Q3 20221$1.43$1.43$1.43
Q4 20221$1.54$1.54$1.54

Horizon Therapeutics Public (NASDAQ HZNP) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/5/2021
(Estimated)
       
2/23/202112/31/2020$1.06$1.28$1.74Transcript
11/7/20209/30/2020$0.97$1.74$2.17$531.11 million$636.40 millionTranscript
8/5/20206/30/2020$0.36$0.40$1.28$333.70 million$462.80 millionTranscript
5/6/20203/31/2020$0.21$0.40$0.95$287.88 million$355.90 millionTranscript
2/26/2020Q4 2019$0.42$0.56($1.72)$349.25 million$363.50 millionTranscript
11/6/2019Q3$0.50$0.64$1.19$330.60 million$335.50 millionTranscript
8/7/2019Q2 2019$0.38$0.52$1.07$296.27 million$320.60 millionListen
5/8/20193/31/2019$0.10$0.30$0.79$238.35 million$280.00 millionListen
2/27/2019Q4 2018$0.54$0.67$0.84$334.22 million$355.50 millionListen
11/7/20189/30/2018$0.50$0.65$1.15$311.84 million$325.30 millionListen
8/8/2018Q2 2018$0.31$0.48$1.16$275.51 million$302.84 millionN/A
5/9/2018Q1 2018$0.11$0.03$1.02$232.05 million$223.88 millionTranscript
2/28/2018Q4 2017$0.22$0.29$0.86$264.48 million$274.22 millionTranscript
11/6/2017Q3 2017$0.22$0.26$0.91$259.74 million$271.60 millionN/A
8/7/2017Q2 2017$0.12$0.41$2.11$237.01 million$289.51 millionListen
5/8/2017Q1 2017$0.25$0.21$0.98$248.71 million$220.90 millionListen
2/27/2017Q416$0.51$0.64$1.81$307.93 million$310.30 millionListen
11/7/2016Q316$0.63$0.70$1.16$270.04 million$273.70 millionListen
8/8/2016Q216$0.50$0.62$0.75$235.43 million$257.40 millionN/A
5/9/2016Q116$0.30$0.34$0.96$197.73 million$204.70 millionN/A
2/29/2016Q415$0.62$0.63$0.89$240.92 million$244.50 millionListen
11/6/2015Q315$0.41$0.59$1.16$185.70 million$292.70 millionListen
8/7/2015Q215$0.32$0.39$0.38$156.41 million$172.80 millionListen
5/8/2015Q115$0.22$0.16$0.48$104.20 million$113.10 millionN/A
2/27/2015Q414$0.23$0.27$0.81$95.50 million$103.80 millionN/A
11/6/2014Q314$0.19$0.24$0.36$73.17 million$75.10 millionN/A
8/7/2014Q214$0.16$0.14$0.66$58.35 million$66.10 millionN/A
5/9/2014Q114$0.01$0.10$3.27$42.69 million$51.90 millionN/A
3/13/2014Q4 2013($0.25)$1.06$32.20 million$43.10 millionN/A
11/8/2013Q3 2013($0.07)($0.06)$18.31 million$31.50 millionN/A
8/9/2013Q2 2013($0.26)($0.23)$16.09 million$17.64 millionN/A
5/10/2013Q1 2013($0.34)($0.32)$9.47 million$9.20 millionTranscript
3/18/2013Q4 2012($0.38)($0.36)N/A
11/13/2012Q312($0.68)($0.39)$4.12 million$7.20 millionListen
8/10/2012Q2 2012($0.66)($0.64)N/A
5/10/2012Q1 2012($0.95)($0.92)N/A
3/23/2012Q4 2011($1.20)($3.91)($3.90)N/A
11/14/2011Q3 2011($0.94)($1.23)($1.16)N/A
8/31/2011Q2 2011($6.02)($4.26)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.